Pharmaceutical Technology, Aug 1, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Aug 1, 2011
From The Editor
Standing Out in the Crowd
By Patricia Van Arnum
Supplier differentiation is increasingly important in the highly competitive arena of pharmaceutical outsourcing.
Articles
Healthy Outlook for Pharma Services
By Jim Miller
Respondents to the 2011 PharmSource-Pharmaceutical Technology Outsourcing Survey paint a positive picture, but concerns linger under the surface. This article is part of a special issue on Outsourcing.
Rx-360 Completes Pilot Audit of Manufacturing Facility: An Industry Case Study from Avantor
By Paul Smaltz , Rick Siberski
Avantor reviews its experience with the Rx-360 shared audit pilot program, which is aimed at protecting the pharmaceutical supply chain. This article is part of a special issue on Outsourcing.
Improving Visibility of the Pharma Supply Chain: Best Practices and Technologies
By David J. Lennard , Daniel R. Matlis
The authors review current industry challenges and trends in managing global supply chains and propose best practices for improving visibility into those networks.
Outsourced Manufacturing Operations
By James Wright , Malcolm Horsley
Manufacturers are facing ever-increasing competition while end users are expecting better value and efficacy. The authors discuss these challenges and offer practical solutions.
Evaluating QbD's Impact on the Outsourced Relationship
An Industry Roundtable Moderated by Patricia Van Arnum and Rich Whitworh. Contract service and technology providers share their perspectives on the influence of quality by design in the expectations between sponsor companies and outsourcing providers.
A Pharma Manufacturer's View of Quality by Design
By Vince McCurdy , Gerry Migliaccio , Roger Nosal , James Spavins
Pfizer's Experience with QbD. This article is part of a special issue on Outsourcing.
Customer Drivers Influencing Supplier Differentiation
By Patricia Van Arnum
The article examines the drivers of customer perception of contract service providers of pharmaceutical development and manufacturing.
Managing Technology Transfer: Developing a Complete CMC Package for an In-Licensed Product
By Sumeet Dagar , Sean Brynjelsen
The authors share their approach and experience working in complex, multicompany environments for in-licensed products to develop successful chemistry, manufacturing, and controls packages for managing outsourcing partnerships.
Achieving Cross-Functional Supplier Integration: A Case-Study Analysis
By Patricia Van Arnum
The article examines a cross-functional supplier integration model to facilitate project management.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here